Total Payments
$310,749
2023 Payments
$6,035
Companies
15
Transactions
428
Medicare Patients
416
Medicare Billing
$42,493
Payment Breakdown by Category
Other$254,121 (81.8%)
Consulting$28,843 (9.3%)
Travel$19,319 (6.2%)
Food & Beverage$8,451 (2.7%)
Education$14.61 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $251,456 | 146 | 80.9% |
| Consulting Fee | $28,843 | 12 | 9.3% |
| Travel and Lodging | $19,319 | 146 | 6.2% |
| Food and Beverage | $8,451 | 121 | 2.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,665 | 1 | 0.9% |
| Education | $14.61 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $141,683 | 201 | $0 (2022) |
| AbbVie Inc. | $53,591 | 66 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $42,735 | 60 | $0 (2022) |
| IMPEL PHARMACEUTICALS INC. | $18,663 | 22 | $0 (2022) |
| Allergan, Inc. | $18,408 | 28 | $0 (2021) |
| Lilly USA, LLC | $9,485 | 14 | $0 (2019) |
| Biohaven Pharmaceuticals, Inc. | $7,026 | 6 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $6,617 | 12 | $0 (2017) |
| Bausch Health US, LLC | $5,195 | 4 | $0 (2019) |
| Biohaven Pharmaceutical Holding Company Ltd. | $4,827 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $6,035 | 8 | AbbVie Inc. ($6,035) |
| 2022 | $61,486 | 74 | ABBVIE INC. ($31,808) |
| 2021 | $39,947 | 39 | AbbVie Inc. ($15,749) |
| 2020 | $24,494 | 35 | Allergan, Inc. ($16,645) |
| 2019 | $62,053 | 85 | Amgen Inc. ($32,506) |
| 2018 | $107,351 | 159 | Amgen Inc. ($91,488) |
| 2017 | $9,383 | 28 | Avanir Pharmaceuticals, Inc. ($6,617) |
All Payment Transactions
428 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/29/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Travel and Lodging | In-kind items and services | $58.95 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Travel and Lodging | In-kind items and services | $45.85 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.37 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $500.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2022 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,200.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2022 | ABBVIE INC. | UBRELVY (Drug) | Travel and Lodging | In-kind items and services | $762.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $88.15 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2022 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,725.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Consulting Fee | Cash or cash equivalent | $4,148.00 | General |
| Category: Migraine | ||||||
| 11/17/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Travel and Lodging | In-kind items and services | $1,059.20 | General |
| Category: Migraine | ||||||
| 11/17/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Travel and Lodging | In-kind items and services | $415.75 | General |
| Category: Migraine | ||||||
| 11/17/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Travel and Lodging | In-kind items and services | $120.35 | General |
| Category: Migraine | ||||||
| 11/17/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | In-kind items and services | $114.05 | General |
| Category: Migraine | ||||||
| 11/17/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Travel and Lodging | In-kind items and services | $65.50 | General |
| Category: Migraine | ||||||
| 11/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2022 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2022 | ABBVIE INC. | UBRELVY (Drug) | Travel and Lodging | In-kind items and services | $37.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2022 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,925.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2022 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 19 | 19 | $4,465 | $1,460 |
| 2022 | 5 | 142 | 178 | $33,307 | $11,300 |
| 2021 | 8 | 214 | 320 | $52,122 | $25,790 |
| 2020 | 2 | 41 | 50 | $9,055 | $3,943 |
Total Patients
416
Total Services
567
Medicare Billing
$42,493
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 19 | $4,465 | $1,460 | 32.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 80 | 116 | $27,260 | $10,863 | 39.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 17 | 17 | $4,460 | $178.64 | 4.0% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 16 | 16 | $431.20 | $103.04 | 23.9% |
| 82248 | Bilirubin level, direct | Office | 2022 | 17 | 17 | $205.70 | $84.94 | 41.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $950.40 | $71.10 | 7.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 75 | 172 | $38,054 | $22,958 | 60.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 13 | $1,940 | $1,154 | 59.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 17 | 18 | $2,520 | $958.50 | 38.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 24 | 26 | $6,821 | $242.95 | 3.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 16 | 16 | $1,267 | $156.94 | 12.4% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2021 | 24 | 27 | $727.65 | $152.53 | 21.0% |
| 82248 | Bilirubin level, direct | Office | 2021 | 22 | 24 | $290.40 | $101.16 | 34.8% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2021 | 23 | 24 | $501.60 | $65.23 | 13.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 29 | 35 | $6,805 | $2,732 | 40.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 15 | $2,250 | $1,211 | 53.8% |
About Dr. James Weintraub, D.O
Dr. James Weintraub, D.O is a Neurology healthcare provider based in Ann Arbor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073606133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Weintraub, D.O has received a total of $310,749 in payments from pharmaceutical and medical device companies, with $6,035 received in 2023. These payments were reported across 428 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($251,456).
As a Medicare-enrolled provider, Weintraub has provided services to 416 Medicare beneficiaries, totaling 567 services with total Medicare billing of $42,493. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Ann Arbor, MI
- Active Since 10/02/2006
- Last Updated 09/08/2008
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1073606133
Products in Payments
- Aimovig (Biological) $74,530
- UBRELVY (Drug) $65,904
- AJOVY (Drug) $25,740
- Trudhesa (Drug) $18,663
- AJOVY (Biological) $12,708
- NURTEC ODT (Drug) $11,853
- ONZETRA Xsail (Drug) $6,617
- QULIPTA (Drug) $6,082
- MIGRANAL (Drug) $5,195
- VYEPTI (Biological) $1,700
- Zembrace (Drug) $686.51
- SUNOSI (Drug) $98.83
- EMGALITY (Drug) $21.85
- AIMOVIG (Biological) $17.95
- TROKENDI XR (Drug) $14.61
- BOTOX THERAPEUTIC (Biological) $13.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Ann Arbor
Wade Cooper, Do, DO
Neurology — Payments: $692,532
Neurology $692,532
Roger Albin, Md, MD
Neurology — Payments: $36,588
Neurology $36,588
Matthew Lorincz, Md, MD
Neurology — Payments: $36,085
Neurology $36,085
Dr. Denise Leung, M.d, M.D
Neurology — Payments: $20,721
Neurology $20,721
Dawn Kleindorfer, Md, MD
Neurology — Payments: $13,978
Neurology $13,978
Charles Schultz, Md, MD
Neurology — Payments: $8,851
Neurology $8,851